Anti-IgE Therapy in Asthma: Rationale and Therapeutic Potential

Publisher： Karger

E-ISSN： 1423-0097|123|3|196-204

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.123, Iss.3, 2000-11, pp. : 196-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-IgE Therapy with Omalizumab Decreases Endothelin-1 in Exhaled Breath Condensate of Patients with Severe Persistent Allergic Asthma

By  

Respiration, Vol. 80, Iss. 6, 2010-06 ,pp. : 534-542

Karger

Access to resources Recommend Favorite

The economic value of anti-IgE in severe persistent, IgE-mediated (allergic) asthma patients: adaptation of INNOVATE to Sweden

By Dewilde S.   Turk F.   Tambour M.   Sandström T.  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1765-1776

Informa Healthcare

Access to resources Recommend Favorite

Mimotope and Anti–Idiotypic Vaccines to Induce an Anti–IgE Response

By  

International Archives of Allergy and Immunology, Vol. 118, Iss. 2-4, 1999-04 ,pp. : 119-121

Karger

Access to resources Recommend Favorite

One Year Administration of Anti-IgE to a Patient with Churg-Strauss Syndrome

By  

International Archives of Allergy and Immunology, Vol. 146, Iss. 2, 2008-01 ,pp. : 176-176

Karger

Access to resources Recommend Favorite

Anti‐IgE for chronic urticaria – are children little adults after all?

By  

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 26, Iss. 6, 2015-09 ,pp. : 488-489

John Wiley & Sons Inc

Access to resources Recommend Favorite